BOSTON, Jan. 9, 2025
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building
the leading platform for cell programming and biosecurity, today
announced that Co-Founder and CEO, Jason
Kelly, is scheduled to present at the 43rd Annual J.P.
Morgan Healthcare Conference on Thursday,
January 16, 2025 at 10:30 a.m.
PT (1:30 p.m. ET).
Further details, a webcast link, and a replay of the
presentation will be posted on the company's investor relations
website at https://investors.ginkgobioworks.com/events.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell
programming, providing flexible, end-to-end services that solve
challenges for organizations across diverse markets, from food and
agriculture to pharmaceuticals to industrial and specialty
chemicals. Ginkgo Biosecurity is building and deploying the
next-generation infrastructure and technologies that global leaders
need to predict, detect, and respond to a wide variety of
biological threats. For more information, visit ginkgobioworks.com
and ginkgobiosecurity.com, read our blog, or follow us on social
media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram
(@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-the-43rd-annual-jp-morgan-healthcare-conference-302346539.html
SOURCE Ginkgo Bioworks